参考文献

［1］Facts ＆ Figures Report：1.5 Million Cancer Deaths Avoided in 2Decades［R］.http：／／www.cancer.org，2014－12－31.

［2］Melloul E，Lesurtel M，Carr B I，et al.Developments in liver transplantation for hepatocellular carcinoma［J］.Semin Oncol，2012，39（4）：510－521.

［3］Peng Z H，Zhang Y J，Chen M S，et al.Radiofrequency Ablation with or without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma：A Prospective Randomized Trial［J］.Journal of Clinical Oncology，2013：426－432.

［4］Sun W，Sohal D，Haller D G，et al.Phase 2trial of bevacizumab，capecitabine，and oxaliplatin in treatment of advanced hepatocellular carcinoma［J］.Cancer，2011，117（14）：3187－3192.(https://www.daowen.com)

［5］Ang S F，Tan S H，Toh H C，et al.Activity of thalidomide and capecitabine in patients with advanced hepatocellular carcinoma［J］.Am J Clin Oncol，2012，35（3）：222－227.

［6］Gish R G，Lencioni R，Bisceglie A M，et al.Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma［J］.Expert Rev Gastroenterol Hepatol，2012，6（2）：173－185.

［7］Huang G，Lai E C，Lau W Y，et al.Posthepatectomy HBV reactivation in hepatitis Brelated hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV－DNA levels［J］.Ann Surg，2013，257（3）：490－505.